Healthcare Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3067 |  MOVE Corvex, Inc. - Common Stock | 14.48 USD | +13.04% | +46.26% | -22.98% | +1392.78% | 400.33 M USD | ||
| 3072 |  TKNO Alpha Teknova, Inc. - Common Stock | 7.43 USD | +4.94% | +3.19% | +39.40% | +74.41% | 398.90 M USD | ||
| 3073 |  CTNM Contineum Therapeutics, Inc. - Common stock | 17.24 USD | +4.17% | +1.71% | +8.91% | +12.90% | 398.23 M USD | ||
| 3084 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.78 USD | +1.70% | -3.82% | +13.27% | -2.85% | 392.18 M USD | ||
| 3105 |  OFIX Orthofix Medical Inc. - Common Stock | 9.38 USD | -0.53% | -2.19% | -22.93% | -41.26% | 382.07 M USD | ||
| 3106 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.11 USD | +3.94% | -1.86% | +4.46% | +348.94% | 382.07 M USD | ||
| 3126 |  SLP Simulations Plus, Inc. - Common Stock | 18.43 USD | +0.05% | +0.16% | +0.60% | +3.13% | 372.74 M USD | ||
| 3130 |  IRD Opus Genetics, Inc. - Common Stock | 4.45 USD | +16.19% | +14.99% | +21.25% | +19.62% | 370.22 M USD | ||
| 3137 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.96 USD | +2.96% | +2.12% | +16.24% | -38.16% | 366.60 M USD | ||
| 3142 |  AGEN Agenus Inc. - Common Stock | 8.09 USD | +1.25% | -2.29% | +3.06% | +90.80% | 364.22 M USD | ||
| 3143 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +4.65% | +1.05% | +2.27% | +27.60% | 364.00 M USD | ||
| 3165 |  CATX Perspective Therapeutics, Inc. Common Stock | 3.11 USD | -0.32% | -4.01% | +2.98% | -7.44% | 355.01 M USD | ||
| 3166 |  UPB Upstream Bio, Inc. - Common Stock | 6.48 USD | -1.07% | -8.86% | +1.25% | -67.62% | 354.92 M USD | ||
| 3182 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.50 USD | +5.04% | +0.81% | +11.11% | +44.51% | 348.84 M USD | ||
| 3189 |  PALI Palisade Bio, Inc. - Common Stock | 1.99 USD | +1.53% | -6.13% | +3.65% | +17.06% | 346.80 M USD | ||
| 3200 |  VMD Viemed Healthcare, Inc. - Common Shares | 8.98 USD | +2.05% | -3.02% | -11.44% | +31.67% | 342.03 M USD | ||
| 3206 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.75 USD | +1.35% | -2.85% | -1.32% | +63.04% | 341.20 M USD | ||
| 3208 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.95 USD | -0.50% | -1.00% | -8.46% | -14.39% | 340.24 M USD | ||
| 3210 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.47 USD | -1.68% | -4.44% | -18.93% | +17.71% | 339.42 M USD | ||
| 3220 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.53 USD | +2.03% | +3.36% | +5.53% | 0.00% | 334.36 M USD |
News Healthcare Stocks
Protean Funds Scandinavia AB August 2026 Partner Letter
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia - Slideshow (NASDAQ:ARWR) 2026-09-02
High Tide: German Expansion Just Added Another Bullish Catalyst (NASDAQ:HITI)
AI Giant Micron, Gold Miners Among 18 Names Landing On Best Stock Screens
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider
Gainers Healthcare Stocks
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0021 | +2000.00% |
 NTRBW Nutriband Inc. - Warrant | 0.5850 | +67.14% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0699 | +58.50% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.2498 | +49.31% |
 BIAF bioAffinity Technologies, Inc. - Common Stock | 9.75 | +47.95% |
 BIAFW bioAffinity Technologies, Inc. - Warrant | 0.2200 | +37.50% |
 BFRGW Bullfrog AI Holdings, Inc. - Warrants | 0.0999 | +33.02% |
 CINGW Cingulate Inc. - Warrants | 0.0113 | +24.18% |
Losers Healthcare Stocks
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.38 | -43.28% |
 CDT CDT Equity Inc. - Common Stock | 0.91 | -38.51% |
 CANF Can-Fite Biopharma Ltd American Depositary Shares, each represe | 2.36 | -27.83% |
 NXGLW NexGel, Inc - Warrant | 0.0123 | -22.64% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.11 | -21.43% |
 APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 2.74 | -20.81% |
 HKPD Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares | 0.15 | -16.67% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.30 | -15.58% |